Want to join the conversation?
In 3Q15, $HSIC's Dental segment revenues dropped 2.5% YoverY to $1.3Bil, while its Animal Health segment recorded revenues of $732.5MM, which were down 3.4% compared to 3Q14. Further, the company's Medical segment and Technology and Value-added services segment revenues climbed 24.3% and 3% respectively, both on a YoverY basis.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.